echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Infection > 【Cell】 First time! Stanford University uses organoids to pinpoint the pathways of the new coronavirus in and out of nasal cells

    【Cell】 First time! Stanford University uses organoids to pinpoint the pathways of the new coronavirus in and out of nasal cells

    • Last Update: 2023-02-01
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    This article is the original of Translational Medicine Network, please indicate the source for reprinting

    Written by Jevin

    The nose is an important component of upper respiratory mucosal immunity, and it participates in host-protected immune homeostasis
    .
    There are two main types of nasal mucosal defenses, physiologically speaking, the barrier composed of tightly bound cilia cells, goblet cells and basal epithelial cells, a bilayer of mucus and a basement membrane is the most important means of defense, but it is unclear which types of cells are the first to be infected
    .

    On January 5, 2023, the Stanford University research team published a research paper online in the prestigious journal Cell, which for the first time detailed the molecular mechanism of respiratory epithelial cells infected by the new coronavirus infection, and the researchers found that the virus attaches to the cilia of epithelial cells through ACE2 receptors, and uses cilia as a channel
    to enter the cell.

    #secsectitle0085

    Research process

     01 

    The researchers used the ALI airway organoid model, which has many nuances
    of airways in the body.
    Notably, this culture has a significant kinetic delay (24-48 h) compared to tissue culture models, and they established tissue culture models
    associated with airway barrier function.

    Using EM and IF microscopy, the researchers tracked the detailed steps
    required for the virus to enter the airways.
    The virus first attaches to airway polycilia via ACE2 receptors, and binding and cilia transport are critical
    for the virus to cross the mucus-mucin protective barrier.
    Consumption of cilia blocks SARS-Co-2 infection in ALI cultures, but consumption of mucin with purified mucinase accelerates viral entry
    .
    At 24-48 h, the number of viruses increases, a large number of rearrangements and amplification of microvilli in epithelial cells and activation of PAK1, PAK4 and SLK
    kinases.
    Inhibitors of these kinases block late viral transmission but cannot bind to cilia initially
    .
    PAK kinase inhibitors attenuated viral transmission
    in mice.

    Study results

     02

    Even at high titers, only a low percentage of SARS-CoV-2 infects cilia HNE
    at 24 hpi.
    As a result, the researchers suspect that the virus cannot penetrate the PCL of most cells and requires a previously unidentified gateway
    .
    Mucus and PCL in the airway epithelium prevent pathogens and particles from entering more than 40 nm
    .
    Wasting MUC1 partially increases influenza infection, indicating the importance of
    PCL as a physical barrier against viruses.

    Using a variety of imaging techniques, the researchers found that SARS-CoV-2 efficiently attaches to the distal end
    of cilia early in infection (< 6 hours).
    Ciliary consumption in nasal epithelial cells inhibits infection without affecting ACE2 and TMPRSS2 levels
    .
    Thus, cilia can act as ACE2-mediated high-density binding lattices, forming affinity traps that allow viral particles to find target cells by multivalently binding "landing pads", resulting in hyperselectivity
    .

    Two non-exclusive entry mechanisms are possible, first, SARS-CoV-2 interacts with ACE2 and TMPRSS2 on the cilia surface, triggering membrane fusion into cilia and releasing a viral RNA genome that can be transported from cilia to the cytoplasm
    via ciliary dynein.
    Alternatively, cilia-attached SARS-CoV-2 can be transported along the cilia surface and bound to ACE2 on the epithelial cell body surface through a cycle of release and rebinding, guiding the virus for TMPRSS2-mediated membrane fusion
    .
    In this case, the viral ACE2 complex can be transported along the cilia to the apical surface
    of epithelial cells via dynein-dependent retrograde flagellar transport.

    Research significance

     03 

    In addition, the team explored whether cell-to-cell contact affected the transfer
    of the virus.
    The respiratory epithelium consists of multiple layers of cells, however, until 48 hpi only the uppermost cells are infected by the virus, and the cells in the lower layer are rarely infected
    .
    Therefore, cell-to-cell contact may not be the only way
    for the virus to spread in the nasal epithelium.
    Although the virus may be transmitted through cell-to-cell contact in the nasal epithelium, researchers believe that transmission depends on the flow
    of mucus on the apical surface.

    Overall, studies have found that the new coronavirus will first infect respiratory ciliate cells, and if cilia are removed, it can prevent infection with the new coronavirus and other respiratory viruses, and at the same time, the invading virus activates the kinase in the cell to promote the formation of the cytoskeleton, and sends the newly formed virus to the mucus layer through a highly extended microvilli structure, thereby improving the transmission ability
    of the virus.

    Resources:

    #secsectitle0085

    Note: This article is intended to introduce the progress of medical research and cannot be used as a reference
    for treatment options.
    If you need health guidance, please go to a regular hospital
    .

    Referrals, live broadcasts/events

    01/12 14:00-16:00 Online

    Olink Multiomics Cohort Forum

    Scan the code to participate for free

    03/02-03 09:00-18:00 Shanghai

    The 2nd Yangtze River Delta Single-cell Omics Technology Application Forum

    Scan the code to participate for free

    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.